Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis

Digestive and Liver Disease

Volumn 42, Issue 12, 2010, Pages 848-853

  Stronati, Laura ^a   Negroni, Anna ^a   Pierdomenico, Maria ^a   D'Ottavio, Chiara ^a   Tirindelli, Donatella ^a   Di Nardo, Giovanni ^b   Oliva, Salvatore ^b   Viola, Franca ^b   Cucchiara, Salvatore ^b  

^a Section of Toxicology and Biomedical Sciences   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Children; Inflammation; Innate immunity; Intestinal mucosa; Ulcerative colitis

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN HD5; ALPHA DEFENSIN HD6; CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 1BETA; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RIP2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ILEUM; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; ULCERATIVE COLITIS; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ALPHA-DEFENSINS; BIOPSY; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; COLON; GENE EXPRESSION; HUMANS; ILEUM; IMMUNITY, INNATE; INTERLEUKIN-1BETA; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650294008     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.04.003     Document Type: Article

References (52)

1. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006, 3:390-407.
2. Monteleone G., Fina D., Caruso R., et al. New mediators of immunity and inflammation in inflammatory bowel disease. Curr Opin Gastroenterol 2006, 22:361-364.
3. Wang T.C., Cominelli F., Fleischer D.E., et al. AGA Institute Future Trends Committee report: the future of gastroenterology training programs in the United States. Gastroenterology 2008, 135:1764-1789.
4. Ogata H., Hibi T. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr Pharm Des 2003, 9:1107-1113.
5. Papadakis K.A., Targan S.R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000, 51:289-298.
6. Rogler G., Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998, 22:382-389.
7. Hisamatsu T., Ogata H., Hibi T. Innate immunity in inflammatory bowel disease: state of the art. Curr Opin Gastroenterol 2008, 24:448-454.
8. Yamamoto-Furusho J.K., Podolsky D.K. Innate immunity in inflammatory bowel disease. World J Gastroenterol 2007, 13:5577-5580.
9. Brown S.J., Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007, 102:2058-2069.
10. Arseneau K.O., Tamagawa H., Pizzarro T.T., et al. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep 2007, 9:508-512.
11. Shaw M.H., Reimer T., Kim Y., et al. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol 2008, 20:1-5.
12. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
13. Inohara N., Ogura Y., Fontalba A., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003, 278:5509-5512.
14. Girardin S.E., Boneca I.G., Viala J., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003, 278:8869-8872.
15. Kobayashi K., Inohara N., Hernandez L.D., et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416:194-199.
16. Ogura Y., Inohara N., Benito A., et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001, 276:4812-4818.
17. Peyrin-Biroulet L., Chamaillard M. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 2007, 13:135-139.
18. Salzman N.H., Underwood M.A., Bevins C.L. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 2007, 19:70-83.
19. Wehkamp J., Salzman N.H., Porter E., et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005, 102:18129-18134.
20. Wehkamp J., Fellermann K., Herrlinger K.R. Mechanisms of disease: defensins in gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2005, 2:406-415.
21. Ogura Y., Lala S., Xin W., et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003, 52:1591-1597.
22. Carvalho R., Hyamas J.S. Diagnosis and management of inflammatory bowel disease in children. Semin Pediatr Surg 2007, 16:164-171.
23. Turner D., Otley A.R., Mack D., Hyams, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007, 133:423-432.
24. Negroni A., Stronati L., Pierdomenico M., et al. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease. Inflamm Bowel Dis 2009, 15:1145-1154.
25. McCready F.J., Bargen J.A., Dockerty M.B., et al. Involvement of the ileum in chronic ulcerative colitis. N Engl J Med 1949, 240:119-127.
26. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533.
27. Steenholdt C., Andersen L., Pedersen G., et al. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease. Scand J Gastroenterol 2009, 44:195-220.
28. Tanaka K. Expression of Toll-like receptors in the intestinal mucosa of patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2008, 2:193-196.
29. Lawrence C.I., Fiocchi C., Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001, 10:445-456.
30. Dieckgraefe B.K., Stenson W.F., Korzenik J.R., et al. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genom 2000, 4:1-11.
31. Haskell H., Andrews C.W., Reddy S.I., et al. Pathologic features and clinical significance of " backwash" ileitis in ulcerative colitis. Am J Surg Pathol 2005, 11:1472-1481.
32. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A., Antonioli D.A., Colletti R.B., et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. Pediatr Gastroenterol Nutr 2007, 44:653-674.
33. Saltzstein S.L., Rosenberg B.F. Ulcerative colitis of the ileum and regional enteritis of the colon: a comparative histopathologic study. Am J Clin Pathol 1963, 40:610-623.
34. Goldstein N., Dulai M. Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn disease. Am J Clin Pathol 2006, 126:365-376.
35. Barada K.A., Mourad F.H., Sawah S.I., et al. Localized colonic inflammation increases cytokine levels in distant small intestinal segments in the rat. Life Sci 2006, 79:2032-2042.
36. Amit-Romach E., Reifen R., Uni Z. Mucosal function in rat jejunum and ileum is altered by induction of colitis. Int J Mol Med 2006, 18:721-727.
37. Yamamoto T., Maruyama Y., Umegae S., et al. Mucosal inflammation in the terminal ileum of ulcerative colitis patients: endoscopic findings and cytokine profiles. Digestive Liver Dis 2008, 40:253-259.
38. Williams H., Walker D., Orchard T.R. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2008, 10:597-605.
39. Rothfuss K.S., Stange E.F., Herrlinger K.R. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 2006, 12:4819-4831.
40. Hata K., Watanabe T., Shinozaki M., et al. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 2003, 38:1005-1008.
41. Kuisma J., Järvinen H., Kahri A., Färkkilä M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004, 39:544-548.
42. Achkar J.P., Al-Haddad M., Lashner B., et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005, 3:60-66.
43. Otte S.J., Kiehne K., Herzig K.H. Antimicrobial peptides in innate immunity of the human intestine. J Gastroenterol 2003, 38:717-726.
44. Wehkamp J., Chu H., Shen B., et al. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett 2006, 580:5344-5350.
45. Fahlgren A., Hammarstrom S., Danielsson Å., et al. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol 2003, 131:90-101.
46. Cunliffe R.N., Rose F.R., Keyte J., et al. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 2001, 48:176-185.
47. Menendez A., Brett Finlay B. Defensins in the immunology of bacterial infections. Curr Opin Immunol 2007, 19:385-391.
48. Simms L.A., Doecke J.D., Walsh M.D., et al. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008, 57:903-910.
49. Bevins C.L., Stange E.F., Wehkamp J., et al. Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype. Gut 2009, 58:882-883.
50. Kiehne K., Brunke G., Wegner F., et al. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 2006, 12:1056-1062.
51. Noble C.L., Abbas A.R., Cornelius J., et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 2008, 57:1398-1405.
52. Shi J. Defensins and Paneth cells in inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:1284-1292.